300026.SZ
红日药业
SZSE · Healthcare · C 制造业 · CN
CNY 3.33
−2.06%Margins
Gross margin
60.0%
EBITDA margin
8.9%
EBIT margin
2.4%
Net margin
0.5%
FCF margin
14.6%
0.3%
Return on equity
0.2%
Return on assets
1.2%
Return on invested capital
0.45x
Asset turnover
CNY 798.8M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026